135 related articles for article (PubMed ID: 17537724)
1. Tumor progression locus-2 is a critical regulator of pancreatic and lung inflammation during acute pancreatitis.
Van Acker GJ; Perides G; Weiss ER; Das S; Tsichlis PN; Steer ML
J Biol Chem; 2007 Jul; 282(30):22140-9. PubMed ID: 17537724
[TBL] [Abstract][Full Text] [Related]
2. Tpl2 Ablation Leads to Hypercytokinemia and Excessive Cellular Infiltration to the Lungs During Late Stages of Influenza Infection.
Latha K; Jamison KF; Watford WT
Front Immunol; 2021; 12():738490. PubMed ID: 34691044
[TBL] [Abstract][Full Text] [Related]
3. Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance.
Perfield JW; Lee Y; Shulman GI; Samuel VT; Jurczak MJ; Chang E; Xie C; Tsichlis PN; Obin MS; Greenberg AS
Diabetes; 2011 Apr; 60(4):1168-76. PubMed ID: 21346175
[TBL] [Abstract][Full Text] [Related]
4. Tpl2 (tumor progression locus 2) phosphorylation at Thr290 is induced by lipopolysaccharide via an Ikappa-B Kinase-beta-dependent pathway and is required for Tpl2 activation by external signals.
Cho J; Melnick M; Solidakis GP; Tsichlis PN
J Biol Chem; 2005 May; 280(21):20442-8. PubMed ID: 15778223
[TBL] [Abstract][Full Text] [Related]
5. Tpl2 promotes neutrophil trafficking, oxidative burst, and bacterial killing.
Acuff NV; Li X; Elmore J; Rada B; Watford WT
J Leukoc Biol; 2017 Jun; 101(6):1325-1333. PubMed ID: 28356348
[TBL] [Abstract][Full Text] [Related]
6. Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production.
Mielke LA; Elkins KL; Wei L; Starr R; Tsichlis PN; O'Shea JJ; Watford WT
J Immunol; 2009 Dec; 183(12):7984-93. PubMed ID: 19933865
[TBL] [Abstract][Full Text] [Related]
7. Tpl2 ablation promotes intestinal inflammation and tumorigenesis in Apcmin mice by inhibiting IL-10 secretion and regulatory T-cell generation.
Serebrennikova OB; Tsatsanis C; Mao C; Gounaris E; Ren W; Siracusa LD; Eliopoulos AG; Khazaie K; Tsichlis PN
Proc Natl Acad Sci U S A; 2012 May; 109(18):E1082-91. PubMed ID: 22451924
[TBL] [Abstract][Full Text] [Related]
8. Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice.
Li X; Liu C; Ip BC; Hu KQ; Smith DE; Greenberg AS; Wang XD
J Exp Clin Cancer Res; 2015 Nov; 34():138. PubMed ID: 26560698
[TBL] [Abstract][Full Text] [Related]
9. Tumor progression locus 2 (Tpl2) deficiency does not protect against obesity-induced metabolic disease.
Lancaster GI; Kowalski GM; Estevez E; Kraakman MJ; Grigoriadis G; Febbraio MA; Gerondakis S; Banerjee A
PLoS One; 2012; 7(6):e39100. PubMed ID: 22701749
[TBL] [Abstract][Full Text] [Related]
10. Tumor progression locus 2 (Tpl2) kinase promotes chemokine receptor expression and macrophage migration during acute inflammation.
Rowley SM; Kuriakose T; Dockery LM; Tran-Nguyen T; Gingerich AD; Wei L; Watford WT
J Biol Chem; 2014 May; 289(22):15788-97. PubMed ID: 24713702
[TBL] [Abstract][Full Text] [Related]
11. The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation.
Senger K; Pham VC; Varfolomeev E; Hackney JA; Corzo CA; Collier J; Lau VWC; Huang Z; Hamidzhadeh K; Caplazi P; Peng I; Setiadi AF; Francis R; Paler-Martinez A; Kwon YC; Ramirez-Carrozzi V; Sun Y; Grigg PW; Roose-Girma M; Jeet S; Barck KH; Pham A; Ota N; Ha C; Stinson J; Guillory J; Tam L; Modrusan Z; Emson C; McKenzie BS; Townsend MJ; Carano RAD; Warming S; Vucic D; DeVoss J; Lee WP; Lill JR; Zarrin AA
Sci Signal; 2017 Apr; 10(475):. PubMed ID: 28420753
[TBL] [Abstract][Full Text] [Related]
12. Tpl2 kinase regulates inflammation but not tumorigenesis in mice.
Wu KC; Cain G; Corpuz J; Xu D; Ljumanovic N; Zarrin AA
Toxicol Appl Pharmacol; 2021 May; 418():115494. PubMed ID: 33722668
[TBL] [Abstract][Full Text] [Related]
13. TPL2 Is a Key Regulator of Intestinal Inflammation in Clostridium difficile Infection.
Wang Y; Wang S; Kelly CP; Feng H; Greenberg A; Sun X
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29844241
[TBL] [Abstract][Full Text] [Related]
14. The Tpl2 Kinase Regulates the COX-2/Prostaglandin E2 Axis in Adipocytes in Inflammatory Conditions.
Berthou F; Ceppo F; Dumas K; Massa F; Vergoni B; Alemany S; Cormont M; Tanti JF
Mol Endocrinol; 2015 Jul; 29(7):1025-36. PubMed ID: 26020725
[TBL] [Abstract][Full Text] [Related]
15. Influenza-induced Tpl2 expression within alveolar epithelial cells is dispensable for host viral control and anti-viral immunity.
Wyatt KD; Sarr D; Sakamoto K; Watford WT
PLoS One; 2022; 17(1):e0262832. PubMed ID: 35051238
[TBL] [Abstract][Full Text] [Related]
16. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
18. TPL2 kinase action and control of inflammation.
Xu D; Matsumoto ML; McKenzie BS; Zarrin AA
Pharmacol Res; 2018 Mar; 129():188-193. PubMed ID: 29183769
[TBL] [Abstract][Full Text] [Related]
19. Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity.
Njunge LW; Estania AP; Guo Y; Liu W; Yang L
Theranostics; 2020; 10(18):8343-8364. PubMed ID: 32724474
[TBL] [Abstract][Full Text] [Related]
20. Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice.
Gong J; Fang C; Zhang P; Wang PX; Qiu Y; Shen LJ; Zhang L; Zhu XY; Tian S; Li F; Wang Z; Huang Z; Wang A; Zhang XD; She ZG
Hepatology; 2019 Feb; 69(2):524-544. PubMed ID: 29381809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
